DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
BankPosition in NAMS — NewAmsterdam Pharma Co N.V.
CIK 1694217
FRANKFURT AM MAIN, 2M
Position in NAMS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,145,169
+$642,748 QoQ
Shares Held
63,298
+34.9% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#94
of 198 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main holds $378,508,495 across 32 Biotechnology names. NAMS ranks #17 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
359,332 | $178,490,982 | |
| 2 | BNTX |
BioNTech SE
|
379,081 | $35,273,485 | |
| 3 | INCY |
Incyte Corp
|
218,950 | $24,820,171 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,792 | $24,188,362 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
551,075 | $20,064,640 | |
| 6 | INVA |
Innoviva, Inc.
|
830,374 | $18,857,793 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
151,301 | $11,996,656 | |
| 8 | AUPH |
Aurinia Pharmaceuticals Inc.
|
596,618 | $10,124,607 |
All Filings in NAMS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,145,169 | 63,298 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,502,421 | 46,936 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,220,634 | 63,302 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||